Current role of alpha-blockers in the treatment of benign prostatic hyperplasia.
Kaplan
Steven A
SA
Institute of Bladder and Prostate Health, Weill Cornell Medical College, Cornell University, New York, NY, USA. kaplans@med.cornell.edu
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D017292:Doxazosin / Q000627:therapeutic use*; D004333:Drug Administration Routes; D006801:Humans; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy*; D053448:Prostatism / Q000188:drug therapy* / Q000209:etiology
D000317:Adrenergic alpha-Antagonists; D017292:Doxazosin